IN2012DN06393A - - Google Patents

Info

Publication number
IN2012DN06393A
IN2012DN06393A IN6393DEN2012A IN2012DN06393A IN 2012DN06393 A IN2012DN06393 A IN 2012DN06393A IN 6393DEN2012 A IN6393DEN2012 A IN 6393DEN2012A IN 2012DN06393 A IN2012DN06393 A IN 2012DN06393A
Authority
IN
India
Prior art keywords
intestine
individual
present
probiotic composition
non secretor
Prior art date
Application number
Inventor
Pirjo Wacklin
Jaana Mättö
Harri Mäkivuokko
Original Assignee
Suomen Punainen Risti Veripalvelu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suomen Punainen Risti Veripalvelu filed Critical Suomen Punainen Risti Veripalvelu
Publication of IN2012DN06393A publication Critical patent/IN2012DN06393A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to a probiotic composition which is tailored based on the spectrum of bifidobacteria found in the intestine of at least one individual with non secretor blood group phenotype. The present invention further relates to a method of tailoring a probiotic composition based on the bifidobacteria found from the intestine of at least one non secretor individual.
IN6393DEN2012 2009-12-28 2010-12-28 IN2012DN06393A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20096400A FI20096400A0 (en) 2009-12-28 2009-12-28 Use of blood group status I
US12/843,404 US20110158950A1 (en) 2009-12-28 2010-07-26 Use of blood group status i
PCT/FI2010/051093 WO2011080395A2 (en) 2009-12-28 2010-12-28 Use of blood group status i

Publications (1)

Publication Number Publication Date
IN2012DN06393A true IN2012DN06393A (en) 2015-10-02

Family

ID=41462858

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6393DEN2012 IN2012DN06393A (en) 2009-12-28 2010-12-28

Country Status (7)

Country Link
US (1) US20110158950A1 (en)
EP (1) EP2519255A2 (en)
CN (1) CN102781466B (en)
BR (1) BR112012016926A2 (en)
FI (1) FI20096400A0 (en)
IN (1) IN2012DN06393A (en)
WO (1) WO2011080395A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2598155A2 (en) * 2010-07-26 2013-06-05 Suomen Punainen Risti Veripalvelu Use of blood group status iii
MX2014012362A (en) * 2012-04-13 2015-05-07 Trustees Boston College Prebiotic compositions and methods of use.
CN105385762A (en) * 2015-12-10 2016-03-09 扬州市扬大康源乳业有限公司 Method for rapidly identifying bifidobacterium
EP3419630A4 (en) 2016-02-24 2019-11-06 Glycom A/S Synthetic composition for microbiota modulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826928A1 (en) * 1998-06-17 1999-12-23 Novartis Consumer Health Gmbh Medicines containing viable anaerobic bacteria that inhibit sulfate reduction by sulfate-reducing bacteria
AU2001233529A1 (en) * 2000-02-10 2001-08-20 Andrew W. Bruce Probiotic therapy for newborns
AU2002329043A1 (en) * 2001-07-30 2003-02-24 Claudio De Simone Treatment of radiation-induced diarrhea with probiotics
JP4709838B2 (en) * 2004-08-05 2011-06-29 アニドラル エス．アール．エル． Folic acid producing Bifidobacterium strains, preparations and uses thereof
ITMI20042189A1 (en) * 2004-11-16 2005-02-16 Anidral Srl COMPOSITION BASED ON PROBIOTIC BACTERIA AND ITS USE IN THE PREVENTION OF E-OR IN THE TREATMENT OF PATHOLOGIES AND-OR RESPIRATORY INFECTIONS AND IN THE IMPROVEMENT OF INTESTINAL FUNCTIONALITY
PT1986669E (en) * 2006-02-15 2012-05-15 Nestec Sa Use of bifidobacterium longum for the prevention and treatment of inflammation
JP5766947B2 (en) * 2007-09-07 2015-08-19 チルドレンズ ホスピタル メディカル センター Use of secreted Lewis and sialylated antigen levels in clinical samples as predictors of disease risk
US20090098088A1 (en) * 2007-10-10 2009-04-16 The Procter & Gamble Company Methods And Kits For The Treatment Of Diverticular Conditions

Also Published As

Publication number Publication date
WO2011080395A2 (en) 2011-07-07
BR112012016926A2 (en) 2019-09-24
CN102781466B (en) 2015-11-25
EP2519255A2 (en) 2012-11-07
US20110158950A1 (en) 2011-06-30
CN102781466A (en) 2012-11-14
FI20096400A0 (en) 2009-12-28
WO2011080395A3 (en) 2011-09-15

Similar Documents

Publication Publication Date Title
IL260293A (en) Azeotrope-like compositions of cis-1,1,1,4,4,4-hexafluoro-2-butene
NZ709392A (en) Synergistic bacterial compositions and methods of production and use thereof
HK1172516A1 (en) Nutritional composition for promoting gut microbiota balance and health
IL215168A0 (en) Compsitions compositions and methods for increasing muscle growth
IL229284A0 (en) Sterilized, acellular extracellular matrix compositions and methods of making thereof
HK1210703A1 (en) Improved methods and compositions for vein harvest and autografting
EP2405918A4 (en) Prebiotic oligosaccharides
EP2464724A4 (en) Compositions and methods for implantation of processed adipose tissue and processed adipose tissue products
MX2018009945A (en) Novel compositions and methods for the treatment of immune related diseases.
PL2513023T3 (en) Compositions and uses of cis-1,1,1,4,4,4-hexafluoro-2-butene
WO2012013861A3 (en) Use of blood group status iii
MX2010008943A (en) Rebaudioside a derivative products and methods for making.
EP2576578A4 (en) Polymorphs of 2'-o-fucosyllactose and producing thereof
MX344786B (en) Compositions and methods for treating gaucher disease.
SG179038A1 (en) Compositions and methods for diagnosing autism spectrum disorders
EP2451300A4 (en) Heat resistant probiotic compositions and healthy food comprising them
EP2515794A4 (en) Dental compositions, mill blocks, and methods
IN2012DN06392A (en)
MY152437A (en) Oral care compositions
GB0905488D0 (en) Organopolysiloxane compositions and their production
AU331248S (en) Symmetrical dental bilateral bite block
MX348325B (en) Galacto-oligosaccharide-containing composition and a method of producing it.
SI2470166T1 (en) New compositions of 1-š2-(2,4-dimethyl-phenylsulfanyl)-phenylćpiperazine
EP2490721A4 (en) Compositions, methods for treatment, and diagnoses of autoimmunity-related disorders and methods for making such compositions
PH12015501099A1 (en) Synbiotic composition and use thereof